Samsara Bio Capital, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Samsara Bio Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$14.69 - $42.57 $988,196 - $2.86 Million	-67,270 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$12.88 - $19.47 $216,602 - $327,426	-16,817 Reduced 20.0%	67,270 $1.28 Million
Q3 2020 Nov 16, 2020	SELL	$9.83 - $13.99 $826,575 - $1.18 Million	-84,087 Reduced 50.0%	84,087 $1.06 Million
Q1 2020 May 15, 2020	BUY	$5.8 - $18.56 $288,109 - $921,949	49,674 Added 41.92%	168,174 $1.29 Million
Q1 2019 May 15, 2019	SELL	$16.51 - $31.1 $520,065 - $979,650	-31,500 Reduced 21.0%	118,500 $3.39 Million
Q4 2018 Feb 14, 2019	BUY	$16.21 - $24.06 $2.43 Million - $3.61 Million	150,000 New	150,000 $2.96 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $216M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.